Envision Pharma Group Acquires doDOC
March 22, 2021
Envision Pharma Group, a portfolio company of GHO Capital Partners, has acquired doDOC Corp., a Boston-founded SaaS platform for collaborative document review and authoring tailored to the life sciences. doDOC will operate as a business unit under its existing brand and be integrated into Envision's iEnvision medical affairs platform to expand document collaboration capabilities and improve workflow efficiency.
- Targets
- doDOC Corp.
- Platforms
- Envision Pharma Group
- Industry
- Software
- Location
- Massachusetts, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
NetDocuments Completes Acquisition of OpenText's eDOCS Business
January 13, 2026
Cloud & SaaS
NetDocuments has completed its acquisition of the eDOCS document management business from OpenText, including the eDOCS product portfolio and its dedicated team. The deal brings the eDOCS platform and customer community under NetDocuments, expanding its global footprint and allowing continued on‑premises support while offering a path to cloud modernization and migration tools.
-
Embrace Software Acquires EPOWERdoc, Inc.
August 1, 2021
Healthcare Services
Embrace Software has acquired EPOWERdoc, Inc., a 20-year leader in Emergency Department Information Systems and telehealth solutions. The acquisition brings EPOWERdoc’s 40+ employees and ED-focused software into Embrace’s portfolio to accelerate product development and expand Embrace’s presence in healthtech.
-
Vision33 Acquires iDocuments from Synantix
February 1, 2021
Software
Vision33 has acquired the iDocuments product suite and the contracts of all related staff from UK-based software publisher Synantix. The acquisition expands Vision33’s automation and ERP integration capabilities for SME customers, and Vision33 plans to invest in growing iDocuments’ UK customer base and bring the solutions to its global marketplace.
-
Envision Pharma Group Acquires Two Labs
November 12, 2020
Healthcare Services
Envision Pharma Group has acquired Two Labs, a Powell, Ohio-based provider of pharmaceutical commercialization, launch planning, market access and market intelligence services. The deal, which follows increased investment in Envision from GHO Capital, strengthens Envision's US presence and expands its launch-excellence capabilities; Excellere Partners will exit its investment in Two Labs.
-
GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian
November 5, 2020
Healthcare Services
GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.
-
Envision Pharma Group Acquires 90TEN
April 8, 2020
Healthcare Services
Envision Pharma Group, a portfolio company backed by Ardian and GHO Capital, has acquired London-based healthcare communications consultancy 90TEN. 90TEN will retain its brand and management, bringing behavioral science-led communications capabilities to Envision's global medical affairs and communications offerings.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.